| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Chief Financial Officer
1 company
Cline Christopher R. serves as a Chief Financial Officer at TVTX. Across recent SEC filings that breaks down to 0 buys and 32 sells. Those positions are worth an estimated $5.7M at current prices.
Historically, Cline Christopher R.'s trades have earned a below-average insider score of 48/100 across 22 rated trades. Over a 12-month horizon, 35.7% of those trades were profitable, with an average 12-month return of -36.2%.
The biggest single holding is TVTX (~$5.7M) as Chief Financial Officer. The recent filings there lean toward selling, a net 111,015 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc. | Chief Financial Officer | Sale+OE10b5-1 | 50,508 | $62.34 | $3,148,543.99 | -36.6% | - | - | |
| Sep 2, 2026 | TVTX Travere Therapeutics, Inc. | Chief Financial Officer | Sell | 642 | $66.37 | $42,609.54 | -0.5% | - | - | |
| May 6, 2026 | TVTX Travere Therapeutics, Inc. | Chief Financial Officer | Sale+OE10b5-1 | 2,491 | $46.31 | $115,368.15 | -2.1% | +25.2% | - | |
| Apr 15, 2026 | TVTX Travere Therapeutics, Inc. | Chief Financial Officer | Sell10b5-1 | 8,327 | $41.91 | $348,974.00 | -6.6% | +39.3% | - | |
| Feb 4, 2026 | TVTX Travere Therapeutics, Inc. | Chief Financial Officer | Sell10b5-1 | 1,745 | $32.19 | $56,167.90 | -1.5% | +41.4% | - | |
| Feb 3, 2026 | TVTX Travere Therapeutics, Inc. | Chief Financial Officer | Sell | 7,242 | $32.12 | $232,613.04 | -6.0% | +36.8% | - | |
| Dec 1, 2025 | TVTX Travere Therapeutics, Inc. | Chief Financial Officer | Sale+OE10b5-1 | 20,000 | $35.01 | $700,202.00 | -17.8% | -16.1% | - | |
| Sep 4, 2025 | TVTX Travere Therapeutics, Inc. | Chief Financial Officer | Sell10b5-1 | 573 | $18.51 | $10,608.29 | -0.6% | +64.8% | +208.7% | |
| Aug 27, 2025 | TVTX Travere Therapeutics, Inc. | Chief Financial Officer | Sell10b5-1 | 470 | $17.31 | $8,135.70 | -0.5% | +106.5% | +287.2% | |
| May 5, 2025 | TVTX Travere Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 1,784 | $21.05 | $37,553.20 | -1.9% | -25.5% | +109.2% |